Law360 and Reuters wrote articles about Parker Poe's Life Sciences Team prevailing in an appeal of a patent infringement lawsuit before the U.S. Court of Appeals for the Federal Circuit. The articles note the ruling clears the way for Banner Life Sciences to proceed with its commercial strategy for a pharmaceutical drug.
Subscribers can find the Law360 article here and the Reuters article here. Both publications are leading national news outlets.
You can also learn more about the case and Parker Poe's Life Sciences Team here.